Penumbra Inc (PEN)
205.71
-0.44
(-0.21%)
USD |
NYSE |
Apr 25, 16:00
205.71
0.00 (0.00%)
After-Hours: 20:00
Penumbra SG&A Expense (Quarterly): 130.02M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 130.02M |
September 30, 2023 | 125.92M |
June 30, 2023 | 127.44M |
March 31, 2023 | 123.08M |
December 31, 2022 | 115.63M |
September 30, 2022 | 108.57M |
June 30, 2022 | 114.62M |
March 31, 2022 | 110.90M |
December 31, 2021 | 113.50M |
September 30, 2021 | 94.40M |
June 30, 2021 | 90.64M |
March 31, 2021 | 79.80M |
December 31, 2020 | 76.60M |
September 30, 2020 | 76.16M |
June 30, 2020 | 59.85M |
March 31, 2020 | 74.45M |
December 31, 2019 | 74.69M |
September 30, 2019 | 69.29M |
June 30, 2019 | 67.66M |
Date | Value |
---|---|
March 31, 2019 | 61.09M |
December 31, 2018 | 61.18M |
September 30, 2018 | 55.93M |
June 30, 2018 | 54.78M |
March 31, 2018 | 54.50M |
December 31, 2017 | 51.47M |
September 30, 2017 | 45.96M |
June 30, 2017 | 44.16M |
March 31, 2017 | 42.72M |
December 31, 2016 | 41.62M |
September 30, 2016 | 37.74M |
June 30, 2016 | 35.88M |
March 31, 2016 | 33.07M |
December 31, 2015 | 29.15M |
September 30, 2015 | 26.76M |
June 30, 2015 | 26.40M |
March 31, 2015 | 19.55M |
December 31, 2014 | 19.43M |
September 30, 2014 | 16.59M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
59.85M
Minimum
Jun 2020
130.02M
Maximum
Dec 2023
96.48M
Average
94.40M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.941B |
Boston Scientific Corp | 1.379B |
Insulet Corp | 212.80M |
Shockwave Medical Inc | 92.06M |
Stereotaxis Inc | 5.83M |